![]()
BRS4-1-10 - Coenzyme Q Biosynthesis & Pool Availability
1. Mission & Overview
Mission
Maintain endogenous Coenzyme Q synthesis, maturation and pool availability to support mitochondrial electron transfer and cellular redox functions.
Intervention Dominance: Diet-Supported — No principal intervention route established
Biochemical necessity is not intervention responsiveness. The uncontrolled exercise cohort cannot establish superiority over dietary supply.
Overview
CoQ availability depends on endogenous synthesis, maturation and distribution between membranes. This PM owns those supply processes; ETC electron transfer remains with PM1 and downstream oxidant handling remains with the existing redox PMs. Genetic CoQ deficiency establishes the importance of intact biosynthesis, but does not establish a general need for CoQ supplements. [1] [2] [3]
Dietary precursor/cofactor supply is a capacity relationship. It does not establish that additional intake increases CoQ synthesis. Plasma exposure, tissue abundance, mitochondrial concentration, redox state and respiratory function must be measured separately. [4] [8]
2. Primary Biological Effects
Maintains CoQ production and compartmental availability → supplies downstream electron-transfer and cellular redox systems; not evidence of enhanced cognition or clinical resilience.
3. Intervention Levers
- Tyrosine
- Methionine
- Vitamin B2
- Iron
Intracellular CoQ, SAM and FAD are represented within the precursor relationships and biological mechanism, without separate dietary admissions.
- Mitochondrial Cofactor Sufficiency
Individual KC inputs
- Iron — supported upstream supply. Iron supports the diiron COQ7 hydroxylase in CoQ biosynthesis.
No PM-specific protocol is admitted. Precursor bypass in inherited HPDL deficiency and oral CoQ supplementation require genotype-, formulation- and tissue-specific appraisal; neither establishes an ordinary-food protocol.
No lifestyle intervention is admitted yet. The supervised training cohort measured muscle CoQ, but lacked an inactive comparison and did not establish synthesis or mitochondrial-normalised adaptation. See SF4 and the associated Evidence Gap.
4. Mechanistic Basis
Summary
Endogenous headgroup and side-chain pathways converge in CoQ maturation. COQ cofactors sustain biosynthetic capacity, while distribution governs which membranes receive the product. Training-associated muscle changes and oral supplementation results address different questions. Age-related serum redox associations do not demonstrate universal tissue depletion. [1] [4] [5] [6] [8] [10]
Tyrosine-derived 4-HPP can enter an HPDL-associated 4-HMA route towards 4-HB; some intervening human assignments remain unresolved. Phenylalanine can supply tyrosine systemically, but did not directly label this route in the non-liver cells tested. Early precursor bypass in HPDL-deficient mice and one patient is not a healthy-population dietary intervention. [2] [3]
Mevalonate-derived IPP/DMAPP supply the PDSS1/2 side-chain pathway. COQ2 prenylates the headgroup. COQ3/5 use SAM; COQ6 uses flavin-linked reducing equivalents; COQ7 is a diiron hydroxylase and COQ9 supports lipid-substrate handling. COQ4 decarboxylation and COQ8 support have been investigated in reconstructed tetrapod machinery. NADPH, NADH, ATP and metal availability have distinct reaction roles; no generic food-to-NADPH-to-CoQ efficacy chain is admitted. [1] [4] [11]
(Boundaries of the mechanism)
This PM covers CoQ production and pool availability. Electron transfer and local antioxidant protection describe downstream uses of the pool.
PARL/STARD7 experiments show that mitochondrial synthesis and export are separately regulated. COQ gene defects and secondary perturbations can impair pools, but circulating CoQ alone cannot diagnose all tissue deficiencies. The reduced and oxidised forms cycle during function; a higher reduced fraction is not automatically superior. [1] [5] [10]
4.1 Scientific Findings (6)
Summary
Distinct propositions concern precursor formation, enzymatic requirements, distribution, training, tissue target engagement and ageing. Human intervention observations do not inherit the certainty of established biochemical reactions.
· Provisionally assessed · Evidence & Audit
Isotope tracing and genetic perturbation establish an HPDL-associated tyrosine-to-CoQ headgroup route in studied human cell models; precursor rescue in HPDL deficiency is supported principally by mice and one treated patient.
What this means
Cancer-cell models are not whole-body nutritional flux. Phenylalanine did not label the route in the tested non-liver cells lacking phenylalanine hydroxylase. The human 4-HMA-to-4-HB enzymatic sequence and tissue contribution remain incompletely assigned. A single patient is not a controlled efficacy trial.
Evidence confidence: · Provisionally assessed · Evidence & Audit
Canonical record ID: PM10-F1
Finding Statement: Isotope tracing and genetic perturbation establish an HPDL-associated tyrosine-to-CoQ headgroup route in studied human cell models; precursor rescue in HPDL deficiency is supported principally by mice and one treated patient.
Synthesised Evidence Confidence: · Provisionally assessed · Evidence & Audit
Synthesis: Banh identified tyrosine-derived 4-hydroxymandelate (4-HMA), HPDL loss/rescue and incorporation into CoQ10 in human cells. Dependence varied with cell density and culture conditions. Shi traced headgroup intermediates in mouse brain and reported early-treatment rescue and one human treatment course. These establish pathway biology and a genotype-specific bypass, not general dietary enhancement.
Synthesis Limitations: Cancer-cell models are not whole-body nutritional flux. Phenylalanine did not label the route in the tested non-liver cells lacking phenylalanine hydroxylase. The human 4-HMA-to-4-HB enzymatic sequence and tissue contribution remain incompletely assigned. A single patient is not a controlled efficacy trial.
Evidence Considered:
- Study
- The polar oxy-metabolome reveals the 4-hydroxymandelate CoQ10 synthesis pathway
- Population
- Human cell lines, isotope tracing, HPDL knockout and wild-type versus catalytic-mutant rescue.
- Result
- Tyrosine-labelled headgroup metabolites and CoQ10 respond to HPDL perturbation; high-density and 3D conditions reveal dependence.
- Effect / Magnitude
- No dietary effective dose is established.
- Evidence Summary
- Tyrosine-labelled headgroup metabolites and CoQ10 respond to HPDL perturbation; high-density and 3D conditions reveal dependence.
- Limitations
- Culture-specific pathways and rescue; not a dietary tyrosine trial.
- Evidence Source
- Bounded external search
- Reference
- [2]
- Study
- Coenzyme Q headgroup intermediates can ameliorate a mitochondrial encephalopathy
- Population
- HPDL-deficient mice; one patient with biallelic HPDL disease.
- Result
- Labelled 4-HMA/4-HB entered brain CoQ; early precursor treatment rescued mice, with later treatment ineffective; one patient improved during treatment.
- Effect / Magnitude
- No dietary effective dose is established.
- Evidence Summary
- Labelled 4-HMA/4-HB entered brain CoQ; early precursor treatment rescued mice, with later treatment ineffective; one patient improved during treatment.
- Limitations
- Developmental timing, genotype and species limit translation. The patient and mouse outcomes are not independent human replication.
- Evidence Source
- Bounded external search
- Reference
- [3]
· Provisionally assessed · Evidence & Audit
Reconstituted tetrapod COQ enzymes use SAM, flavin-linked electron transfer and a diiron hydroxylase during CoQ headgroup maturation; this identifies biochemical capacity dependencies rather than a benefit from extra nutrient intake.
What this means
Ancestral proteins and CoQ1 assay substrates are not intact human mitochondrial CoQ10 synthesis. FAD dependence is not proof that riboflavin intake limits flux. Cellular metal toxicity is not a reason to supplement cobalt or manganese. Mg/Zn assay roles do not automatically establish new dietary requirements.
Evidence confidence: · Provisionally assessed · Evidence & Audit
Canonical record ID: PM10-F2
Finding Statement: Reconstituted tetrapod COQ enzymes use SAM, flavin-linked electron transfer and a diiron hydroxylase during CoQ headgroup maturation; this identifies biochemical capacity dependencies rather than a benefit from extra nutrient intake.
Synthesised Evidence Confidence: · Provisionally assessed · Evidence & Audit
Synthesis: Nicoll reconstituted ancestral tetrapod COQ3–9 with short-chain substrates and omission controls. COQ3/COQ5 use SAM; COQ6 uses FAD and the FDXR–FDX2 electron-transfer system with upstream NADPH. COQ7 is a diiron hydroxylase supported by COQ9. Cellular metal perturbation provides complementary COQ7 evidence. COQ4 catalyses oxidative decarboxylation in the reconstructed system; COQ8A/B support the machinery rather than naming a CoQ homologue.
Synthesis Limitations: Ancestral proteins and CoQ1 assay substrates are not intact human mitochondrial CoQ10 synthesis. FAD dependence is not proof that riboflavin intake limits flux. Cellular metal toxicity is not a reason to supplement cobalt or manganese. Mg/Zn assay roles do not automatically establish new dietary requirements.
Evidence Considered:
- Study
- In vitro construction of the COQ metabolon unveils the molecular determinants of coenzyme Q biosynthesis
- Population
- Purified reconstructed tetrapod COQ proteins, more than 75% human sequence identity, expressed in bacteria; short-tail substrate assays.
- Result
- Cofactor/enzyme omission and product analysis establish distinct methylation, hydroxylation and assembly reactions.
- Effect / Magnitude
- No dietary effective dose is established.
- Evidence Summary
- Cofactor/enzyme omission and product analysis establish distinct methylation, hydroxylation and assembly reactions.
- Limitations
- Native human regulation, long-tail substrate handling and dietary responsiveness were not measured.
- Evidence Source
- Bounded external search
- Reference
- [4]
- Study
- The CoQ biosynthetic di-iron carboxylate hydroxylase COQ7 is inhibited by in vivo metalation with manganese but remains functional by metalation with cobalt
- Population
- Mouse RAW264.7 and human HEK293 cells under high metal exposures.
- Result
- Manganese exposure increased demethoxy-CoQ/CoQ and iron accelerated recovery after washout.
- Effect / Magnitude
- No dietary effective dose is established.
- Evidence Summary
- Manganese exposure increased demethoxy-CoQ/CoQ and iron accelerated recovery after washout.
- Limitations
- Metal substitution interpretation and supraphysiological exposures do not quantify normal dietary iron limitation.
- Evidence Source
- Bounded external search
- Reference
- [11]
· Provisionally assessed · Evidence & Audit
PARL-dependent STARD7 localisation regulates mitochondrial CoQ synthesis and export to other membranes in experimental cell systems, showing that total CoQ abundance and compartmental availability are distinct.
What this means
Cell and mouse genetic experiments do not establish a dietary transport intervention or the corresponding quantitative fluxes in healthy human tissues.
Evidence confidence: · Provisionally assessed · Evidence & Audit
Canonical record ID: PM10-F3
Finding Statement: PARL-dependent STARD7 localisation regulates mitochondrial CoQ synthesis and export to other membranes in experimental cell systems, showing that total CoQ abundance and compartmental availability are distinct.
Synthesised Evidence Confidence: · Provisionally assessed · Evidence & Audit
Synthesis: Genetic loss and compartment-targeted rescue distinguish mitochondrial STARD7 support of CoQ production from cytosolic STARD7-mediated distribution. Redirecting CoQ towards the plasma membrane can reduce the mitochondrial pool. Findings support compartmental control, not a universal benefit from a larger circulating pool.
Synthesis Limitations: Cell and mouse genetic experiments do not establish a dietary transport intervention or the corresponding quantitative fluxes in healthy human tissues.
Evidence Considered:
- Study
- Mitochondria regulate intracellular coenzyme Q transport and ferroptotic resistance via STARD7
- Population
- Human cultured cells, targeted genetic rescue and mouse PARL-deficiency tissues.
- Result
- STARD7 localisation separates CoQ synthesis and intracellular transport.
- Effect / Magnitude
- No dietary effective dose is established.
- Evidence Summary
- STARD7 localisation separates CoQ synthesis and intracellular transport.
- Limitations
- Cellular ferroptosis resistance is a downstream readout; not cognition, diet or clinical resilience.
- Evidence Source
- Bounded external search
- Reference
- [5]
· Provisionally assessed · Evidence & Audit
In the studied statin-user and non-user cohort, twelve weeks of combined endurance and resistance training was associated with a modest increase in total CoQ10 per gram of wet skeletal muscle.
What this means
No inactive comparison, some missing biopsies, sex/statin differences and one cohort. Concentration per wet mass is not mitochondrial-normalised concentration, synthesis rate, turnover, redistribution or redox state. CoQ change was not shown to mediate function.
Evidence confidence: · Provisionally assessed · Evidence & Audit
Canonical record ID: PM10-F4
Finding Statement: In the studied statin-user and non-user cohort, twelve weeks of combined endurance and resistance training was associated with a modest increase in total CoQ10 per gram of wet skeletal muscle.
Synthesised Evidence Confidence: · Provisionally assessed · Evidence & Audit
Synthesis: The CoQ analysis reused biopsies from the 2021 STATEX training cohort, not a new independent trial. All participants trained. The pooled adjusted change was 3.4 micrograms/g wet muscle (95% CI 0.4–6.3); statin subgroup changes were not individually significant. The earlier report found increased citrate-synthase activity, but no detectable increase in ATP-production capacity or peak oxygen uptake.
Synthesis Limitations: No inactive comparison, some missing biopsies, sex/statin differences and one cohort. Concentration per wet mass is not mitochondrial-normalised concentration, synthesis rate, turnover, redistribution or redox state. CoQ change was not shown to mediate function.
Evidence Considered:
- Study
- The Effect of Exercise Training on Muscle Coenzyme Q10 in Symptomatic and Asymptomatic Statin Users
- Population
- 16 symptomatic and 16 asymptomatic statin users plus 20 non-users; approximately 63–64 years.
- Result
- Pooled muscle CoQ rose after training; baseline CoQ did not distinguish statin muscle-symptom groups.
- Effect / Magnitude
- Adjusted change 3.4 micrograms/g wet muscle, 95% CI 0.4–6.3; P=0.028.
- Evidence Summary
- Pooled muscle CoQ rose after training; baseline CoQ did not distinguish statin muscle-symptom groups.
- Limitations
- All groups trained; subgroup and missing-biopsy limitations; no CoQ synthesis or redox flux.
- Evidence Source
- Bounded external search
- Reference
- [6]
- Study
- Moderate Intensity Exercise Training Improves Skeletal Muscle Performance in Symptomatic and Asymptomatic Statin Users
- Population
- Same STATEX cohort; supervised twelve-week programme.
- Result
- Twice-weekly cycling plus weekly resistance work; citrate-synthase activity increased, ATP-production capacity and peak oxygen uptake did not.
- Effect / Magnitude
- Cycling: 10-minute warm-up, 40 minutes at 70–80% maximal heart rate, 5-minute cool-down, twice weekly; resistance: 60 minutes weekly, 3 sets of 12 repetitions.
- Evidence Summary
- Twice-weekly cycling plus weekly resistance work; citrate-synthase activity increased, ATP-production capacity and peak oxygen uptake did not.
- Limitations
- Same participants as the 2023 CoQ report; not replication.
- Evidence Source
- Bounded external search
- Reference
- [7]
Evidence Dependency:
- Allard 2021 and 2023 are one cohort, not independent replications.
Pending appraisal · Evidence & Audit
In the reported older-adult and statin-treated trials, oral CoQ10 increased plasma exposure without a detectable increase in measured skeletal-muscle CoQ or mitochondrial function under the tested conditions.
What this means
Formulation, tissue, baseline deficiency and population matter. The 2026 abstract does not provide effect intervals or its cognitive result. Cooke reports borderline muscle signals in younger adults, and cardiac-surgical ubiquinol research concerns a different tissue/context; these are not general muscle-delivery proof.
Evidence confidence: Pending appraisal · Evidence & Audit
Canonical record ID: PM10-F5
Finding Statement: In the reported older-adult and statin-treated trials, oral CoQ10 increased plasma exposure without a detectable increase in measured skeletal-muscle CoQ or mitochondrial function under the tested conditions.
Synthesised Evidence Confidence: Pending appraisal · Evidence & Audit
Synthesis: The 2026 trial randomised 40 robust older adults (74 ± 4 years) to 400 mg/day or placebo for twelve weeks. Its abstract reports no change in muscle or isolated-mitochondrial CoQ, respiration, hydrogen-peroxide emission or mitochondrial content despite higher plasma CoQ. Dohlmann studied 37 simvastatin-treated adults for eight weeks at 400 mg/day with similarly null muscle/function results. Full 2026 methods remain unavailable. Neither study proves equivalence or universal inefficacy.
Synthesis Limitations: Formulation, tissue, baseline deficiency and population matter. The 2026 abstract does not provide effect intervals or its cognitive result. Cooke reports borderline muscle signals in younger adults, and cardiac-surgical ubiquinol research concerns a different tissue/context; these are not general muscle-delivery proof.
Evidence Considered:
- Study
- Coenzyme Q10 supplementation raises plasma levels without improving mitochondrial function in older adults
- Population
- 40 robust community-dwelling older adults, 74 ± 4 years; randomised double-blind placebo-controlled trial.
- Result
- Plasma rose; measured muscle/isolated mitochondrial CoQ and respiratory endpoints did not change detectably.
- Effect / Magnitude
- 400 mg/day for twelve weeks; no group effect intervals available in retrieved abstract.
- Evidence Summary
- Plasma rose; measured muscle/isolated mitochondrial CoQ and respiratory endpoints did not change detectably.
- Limitations
- Abstract-level retrieval; null results are not equivalence; cognitive outcome not extracted.
- Evidence Source
- Bounded external search
- Reference
- [8]
- Study
- Coenzyme Q10 Supplementation in Statin Treated Patients: A Double-Blinded Randomized Placebo-Controlled Trial
- Population
- 37 simvastatin-treated men and women with/without myalgia; randomised double-blind placebo-controlled trial.
- Result
- Muscle CoQ and respiration did not improve detectably; muscle changes did not correlate with myalgia changes.
- Effect / Magnitude
- 400 mg/day for eight weeks.
- Evidence Summary
- Muscle CoQ and respiration did not improve detectably; muscle changes did not correlate with myalgia changes.
- Limitations
- Small trial powered partly from plasma/previous mitochondrial data, not a muscle-CoQ equivalence margin.
- Evidence Source
- Bounded external search
- Reference
- [9]
Connected / Supportive Evidence:
- Cooke et al. (2008) [15] — Human StudyWhy relevant: Different formulation, population or tissue provides a boundary against universal non-delivery.Why excluded from the primary synthesis: Not replication of the exact older-adult skeletal-muscle proposition; no pooled effect inferred.
- Orlando et al. (2020) [16] — Human StudyWhy relevant: Different formulation, population or tissue provides a boundary against universal non-delivery.Why excluded from the primary synthesis: Not replication of the exact older-adult skeletal-muscle proposition; no pooled effect inferred.
· Provisionally assessed · Evidence & Audit
In a cross-sectional European sample, older adults had a higher oxidised serum-CoQ10 fraction, while the age pattern in cholesterol-adjusted total CoQ10 was not statistically significant.
What this means
Cross-sectional serum measurements cannot demonstrate longitudinal loss in every tissue, altered biosynthetic flux or an optimal reduced fraction. Normal CoQ function requires reversible redox cycling. Sample processing can cause ex-vivo oxidation.
Evidence confidence: · Provisionally assessed · Evidence & Audit
Canonical record ID: PM10-F6
Finding Statement: In a cross-sectional European sample, older adults had a higher oxidised serum-CoQ10 fraction, while the age pattern in cholesterol-adjusted total CoQ10 was not statistically significant.
Synthesised Evidence Confidence: · Provisionally assessed · Evidence & Audit
Synthesis: Niklowitz studied 860 adults aged 18–82. Unadjusted total CoQ followed an inverse-U pattern, with strong lipoprotein association. Serum handling affected the oxidised fraction; serum and plasma are not interchangeable. A separate short ubiquinol exposure in younger men does not establish reversal of tissue ageing.
Synthesis Limitations: Cross-sectional serum measurements cannot demonstrate longitudinal loss in every tissue, altered biosynthetic flux or an optimal reduced fraction. Normal CoQ function requires reversible redox cycling. Sample processing can cause ex-vivo oxidation.
Evidence Considered:
- Study
- Coenzyme Q10 serum concentration and redox status in European adults: influence of age, sex, and lipoprotein concentration
- Population
- 860 adults, 18–82 years; selected European cohorts, cross-sectional.
- Result
- Older groups had higher oxidised fractions; cholesterol-adjusted total age course was not significant.
- Effect / Magnitude
- Age groups n=326, 388 and 146; mean oxidised serum fraction 12.9%; no causal age-effect estimate.
- Evidence Summary
- Older groups had higher oxidised fractions; cholesterol-adjusted total age course was not significant.
- Limitations
- Selection, residual confounding, serum/plasma matrix and processing; supplementary exposure group comprised younger men.
- Evidence Source
- Bounded external search
- Reference
- [10]
5. BRS Pathways and Connections
5.1 BRS Pathways
CoQ production and distribution supply BRS4-FM1-PM1 — Electron Transport Chain Function. This connection does not duplicate ownership of electron transfer.
5.2 Cross-BRS Mechanism Relationships
BRS2 methyl-donor metabolism can supply SAM; BRS3 uses CoQ-dependent redox functions downstream. BRS1 neurotransmission, BRS5 metabolic/inflammatory signalling and BRS6 adaptive fuel supply are possible contexts for energetic-demand research, not demonstrated causal CoQ intervention pathways. [1] [4]
The Energetic Reserve Hypothesis is recorded as an Evidence Gap: baseline energetic status might modify responses during demand and recovery. CoQ10, creatine, carnitine and microbial metabolites do not share one mechanism. ADHD, cognition or fatigue outcomes do not independently measure mitochondrial mediation, allostatic load or resilience. [13]
5.3 Local BRS Mechanism Relationships
NAD metabolism and the creatine buffer are distinct operations; mitochondrial biogenesis governs organelle capacity rather than CoQ production. No existing PM mission or KC membership is changed.
7. Phenome Connections
These mappings are translational relationships, not single-mechanism outcome claims. Phenomes are emergent functional patterns supported by multiple interacting PMs across the BRAIN Framework.
Each Phenome relationship has two independent ratings. They are not combined or averaged.
Biology → Phenome Relationship Strength
How direct and important is this biological mechanism expected to be to the Phenome within the BRAIN model?
Evidence Confidence
How strongly does the adjudicated evidence support this particular biology → Phenome relationship?
No direct functional outcome relationship currently mapped.
8. References
- [1] Guerra and Pagliarini (2023)
- [2] Banh et al. (2021)
- [3] Shi et al. (2025)
- [4] Nicoll et al. (2024)
- [5] Deshwal et al. (2023)
- [6] Allard et al. (2023)
- [7] Allard et al. (2021)
- [8] Schmücker et al. (2026)
- [9] Dohlmann et al. (2022)
- [10] Niklowitz et al. (2016)
- [11] Wang and Hekimi (2022)
- [12] Žmitek et al. (2014)
- [13] Gamal et al. (2022)
- [14] Liu et al. (2026)
- [15] Cooke et al. (2008)
- [16] Orlando et al. (2020)